Showing 1 to 2 of 2 results


PBMs Delay Life-Saving Medications: Urgent Call for Congressional Reform
A cancer center CEO details a 10-week delay in her daughter's medication approval due to PBM interference, highlighting the systemic issues causing patient suffering and the need for immediate Congressional reform to prioritize patients over profits, despite a failed attempt in 2024.
PBMs Delay Life-Saving Medications: Urgent Call for Congressional Reform
A cancer center CEO details a 10-week delay in her daughter's medication approval due to PBM interference, highlighting the systemic issues causing patient suffering and the need for immediate Congressional reform to prioritize patients over profits, despite a failed attempt in 2024.
Progress
60% Bias Score

FTC Accuses PBMs of \$8.7 Billion in Price Gouging
The FTC released a report accusing the three largest Pharmacy Benefit Managers (PBMs)—OptumRx, Express Scripts, and CVS Caremark—of marking up specialty generic drug prices by over \$7.3 billion from 2017-2022, and an additional \$1.4 billion through spread pricing, ultimately increasing patient cos...

FTC Accuses PBMs of \$8.7 Billion in Price Gouging
The FTC released a report accusing the three largest Pharmacy Benefit Managers (PBMs)—OptumRx, Express Scripts, and CVS Caremark—of marking up specialty generic drug prices by over \$7.3 billion from 2017-2022, and an additional \$1.4 billion through spread pricing, ultimately increasing patient cos...
Progress
24% Bias Score
Showing 1 to 2 of 2 results